Vitamins and minerals for women: recent programs and intervention trials

Ted Greiner

doi:10.4162/nrp.2011.5.1.3

Journal List > Nutr Res Pract > v.5(1) > 1051153

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Greiner: Vitamins and minerals for women: recent programs and intervention trials

Invited Review Article

Nutrition Research and Practice

Nutrition Research and Practice 2011; 5(1): 3-10.

Published online: 28 February 2011

DOI: https://doi.org/10.4162/nrp.2011.5.1.3

Vitamins and minerals for women: recent programs and intervention trials

Ted Greiner

Department of Food and Nutrition, College of Human Ecology, Hanyang University, 17 Haengdang-dong, Seoul 133-791, Korea.

Corresponding Author: Ted Greiner, Tel. 82-2-2220-1208, Fax. 82-2-2292-1226, tgreiner@hanyang.ac.kr

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Women's nutrition has received little attention in nutrition programming, even though clinical trials and intervention trials have suggested that dietary improvement or supplementation with several nutrients may improve their health, especially in low-income settings, the main focus of this paper. Most attention so far has focused on how improvements in maternal nutrition can improve health outcomes for infants and young children. Adequate vitamin D and calcium nutrition throughout life may reduce the risk of osteoporosis, and calcium supplementation during pregnancy may reduce preeclampsia and low birth weight. To reduce neural tube defects, additional folic acid and possibly vitamin B₁₂ need to be provided to non-deficient women before they know they are pregnant. This is best achieved by fortifying a staple food. It is unclear whether maternal vitamin A supplementation will lead to improved health outcomes for mother or child. Iron, iodine and zinc supplementation are widely needed for deficient women. Multimicronutrient supplementation (MMS) in place of the more common iron-folate supplements given in pregnancy in low-income countries may slightly increase birth weight, but its impact on neonatal mortality and other outcomes is unclear. More sustainable alternative approaches deserve greater research attention.

Keywords: Maternal nutrition, multimicronutrient supplementation, vitamins, minerals, low birth weight

Introduction

Nature has given women additional challenges in their role as the bearers and early nurturers of children-which in some sense act as sizable parasites. This places women more at nutritional risk, especially where fertility rates are high, as they tend to be in low-income countries. Poor nutritional status, infection, and a heavy and stressful workload all contribute to increasing a woman's risk of health problems.

Interest in women's nutrition has grown rapidly in recent years but this is mainly because of its relation to child growth, especially nutritional stunting once it was realized that this begins at birth, with most of the insult in height growth taking place in infancy. In Malawi for example, 40% of the growth stunting that occurrs by three years of life has already taken place by 6 months of age [1]. Some have suggested that maternal nutrition during gestation and breastfeeding may be involved [2]. This has led to speculation that treating women with multivitamin and mineral supplements during and after pregnancy might reduce this process of stunting in infants.

Greiner suggested an alternative hypothesis, that early infant retardation in linear growth could to a great extent, be caused by the nearly universal lack of exclusive breastfeeding [3]. This is because in low income countries the foods and fluids given in the early months of life (which always displace breast milk to a large extent), even if they are adequate in energy, lack the other nutrients needed for height growth. In wealthier settings, milk, infant formula or fortified baby foods are more commonly given, and nutritional stunting is not among the known health consequences of the failure to breast feed exclusively. Particularly important for height growth are proteins and minerals, levels of which vary quite little in breast milk, except for the soluble and often endemically deficient minerals iodine and selenium [4].

We know that suboptimal nutrient intakes among women can have an impact on health, including pregnancy outcomes, bone development, immune function, and, in the elderly, neurological function [5]. This review will examine experience in addressing women's nutrient deficiencies at public health level. Ideally, this should be done by reviewing evaluations of public health programs. However, few such programs exist and evaluations of them are rare. Thus, the main focus here will be on intervention research that has been conducted during the past decade or so in women of about 15-45 years of age. This kind of research has been conducted mainly in low-income settings.

Some indirect interventions may have the greatest influence on maternal vitamin and mineral status such as delaying the first conception in young women, increased birth spacing, extending the period of paid maternity leave for working women, and better and earlier treatment of maternal infections. And of course women will benefit from overall strategies to improve vitamin and mineral nutrition such as the Global Alliance for Improved Nutrition (GAIN)-led Ten Year Strategy for the Reduction of Vitamin and Mineral Deficiencies [6]. However, this review focuses on specific interventions or intervention research aiming to improve vitamin and/or mineral status among women, first for their own health and then for that of their offspring.

Nutrient deficiencies linked to public health problems in women

Calcium and vitamin D

Calcium (1,200 mg elemental Ca/d) was found to reduce all four premenstrual syndrome symptoms examined in an older clinical trial [7]. It has even been suggested that PMS may be a marker for inadequate calcium intake [8].

Calcium supplementation during pregnancy (≥ 1 g/d) appears to reduce maternal blood pressure, approximately halve the risk of pre-eclampsia, and reduce the risk of preterm birth, with no evidence of doing harm [9]. This appears to be due to correcting deficiency (suboptimal calcium intake is common in women, even in rich countries) rather than a pharmaceutical effect.

Adequate vitamin D and calcium nutrition throughout the life-course appear to reduce the risk of osteoporosis [10]. So far there is no conclusive evidence that supplementation with any other nutrients has a beneficial impact on bone health [11].

Iron

Women tend to be more susceptible to iron deficiency than men because of monthly blood losses during their reproductive years, and the 10% who lose the most (> 80 ml/mo) are most at risk [12]. Intrauterine contractive devises may increase monthly losses by 30-50%, though levonorgestrel-releasing intrauterine systems reduce this problem [13]. Oral contraceptives and intensive breastfeeding [14] tend to reduce maternal iron losses during reproduction.

Pregnancy and delivery are the source of the greatest iron losses and hemorrhaging during delivery is a major cause of maternal mortality, with women suffering from anemia at increased risk [15]. Iron supplementation during pregnancy can improve maternal iron status, but only if begun early enough and where adherence is high [16]. While deficiencies of several nutrients besides iron can cause anemia, and some nutrients like vitamin A are often linked to iron status, a recent review found no greater impact of a multimicronutrient supplement on iron status than supplementing with iron alone [17].

Anemia increases the risk of preterm delivery and low birth weight (LBW). But high maternal iron levels are associated with an increased risk of fetal growth restriction, preterm delivery, and preeclampsia. High iron levels cause oxidative stress and are also linked to gestational diabetes [18]. Thus in general, where infrastructure will allow it would probably be wiser to ensure that a pregnant woman is iron deficient before giving her iron supplementation during pregnancy, at least in large doses.

Vitamin A

Vitamin A policymaking has focused on providing large doses, either to young children or to women soon after delivery [19], actively reducing the attention given to alternative approaches [20]. (Giving a dose larger than 10,000 IU, less than a two-day supply, at any other time to women in the reproductive age group is considered unethical, since higher doses may be associated with birth defects in women who do not yet know they are pregnant.) While women do receive large doses soon after delivery in some countries, the purpose of this is to increase levels in their breast milk. A recent systematic analysis failed to find any other benefit [21]. One trial in Nepal found that giving pregnant women frequent small doses of vitamin A reduced maternal mortality by 44% [22]. Later trials within less vitamin A deficient populations in Bangladesh [23] and Ghana [24] failed to find any impact.

Kirkwood argues that even the Nepal study provides inconclusive evidence, and thus, there is presently inadequate support for including low-dose vitamin-A supplementation for women in safe motherhood programs [25].

Vitamin E

One older placebo controlled trial found that a daily dose of 400 IU/d for three months led to a reduction in symptoms of premenstrual syndrome [26]. Results have been inconsistent for other supplements such as large doses of vitamin B₆ and evening primrose oil.

Zinc

There is some evidence that zinc deficiency may be involved in some maternal mental health problems. In one study, 25 mg/d of zinc, along with medical treatment, improved depression more rapidly than medical treatment alone. Anorexia nervosa patients also improved more rapidly with zinc therapy [27].

Multivitamins

In one study, the use of prenatal multivitamins was found to lead to easier pregnancies (such as less morning sickness) [8].

Health problems of the fetus or child linked to maternal nutrient deficiency

Most vitamin and many mineral deficiencies in the mother, if serious enough, are likely to have any of a range of impacts on her offspring. But major attention must be placed on mortality, as well as birth defects and LBW, both major causes of infant morbidity and mortality. We begin with single nutrient interventions and then move to the major issue attracting research attention in recent years, multimicronutrient supplementation (MMS) of pregnant women.

Single nutrients

Birth defects

Some studies have found a number of apparent benefits from taking prenatal vitamins, including reductions in heart, neural tube, and other birth defects [8]. However, the focus here will be on the outcome that has been most strongly confirmed and acted on, neural tube defects. Additional folic acid needs to be provided to women at the very beginning of pregnancy to reduce the incidence of neural tube defects (recognizing that other birth defects may be affected as well). Programs to improve folate nutrition have been introduced in 40 countries, but they represent only about 10% of the neural tube defects that could be prevented [28]. In particular, advising women to take prenatal supplements is ineffective [29]. This is partly because once a woman knows she is pregnant, the neural tube has already folded, and partly because, even with encouragement, too few women take them regularly enough. Thus impact can best be accomplished through mandatory fortification of a universally consumed food. While most staple food fortification has focused on wheat (and to a lesser extent on maize), when rice is the staple food, it can be fortified at low cost with no impact on taste or appearance [30].

Recent research suggests that vitamin B₁₂ deficiency may also be involved in the causation of neural tube defects [31]. Among other arguments for combining B₁₂ with folate in fortification programs, there is some evidence that high folate combined with low B₁₂ levels in pregnant women predisposes children to insulin resistance [32].

Infant morbidity

A study in West Java found that zinc supplementation in pregnant mothers led to a decreased incidence of diarrhea but an increase in episodes of cough during the first six months of infancy. Both zinc and β-carotene appeared to have an impact on the infant immune system [33]. Prenatal zinc supplementation was also found to reduce infant diarrhea in Indonesia [33] and Peru [34].

Birthweight

Even countries with high rates of low birthweight rarely have any defined programs to reduce it [35]. At the end of the 1990s, there were no known interventions with single vitamins and minerals that would decrease rates of intrauterine growth retardation [36], but the lack of good research was noted by the investigators.

Since then a great deal of additional research on this issue has been done. With respect to single nutrients, a systematic review found good evidence that calcium supplementation at > 1 g/day during pregnancy resulted in an average 17% reduction in LBW [37]. This effect may be due both to a prolongation of gestation and an increase in fetal growth. This same review found that the impact of magnesium supplementation during pregnancy may be even greater, but sample sizes so far have been slightly too small to be certain. The review found no significant impact of supplementation with other single nutrients on fetal growth.

However in deficient mothers, supplementation with iodine [38] and iron [39] can increase birthweight. For iodine, this is associated with neonatal survival [40] as well as IQ. One study found that zinc (with routine iron-folate) did not increase birthweight [41]. But among African American women with low levels of serum zinc at baseline, supplementation with 25 mg of zinc (in women taking non-zinc containing prenatal MMS) resulted in a 285 g increase in birthweights [42].

Iron-folate supplementation during pregnancy has sometimes been found to improve a number of developmental outcomes in young children [43], and sometimes not [44]; also, zinc has not [45].

Multimicronutrient supplementation during pregnancy

Birthweight

During the past decade, the most extensive relevant research has involved supplementation of pregnant women with multimicronutrients, including a multi-site UNICEF study using approximately the recommended daily intakes of iron, folic acid, zinc, copper, selenium, iodine, and vitamins A, B₁, B₂, B₃, B₆, B₁₂, C, D, and E. (Note that this MMS did not include calcium or magnesium and used 30 mg of iron half the dose of what is often given in iron-folic acid supplements. However, a 60 mg dose is probably higher than necessary [46].) This research has focused on relatively large and "normal" populations, rather than on patients with clinical deficiencies.

A Cochrane review of MMS during pregnancy in 2006 found that it worked better than placebo but not better than iron-folate supplementation to reduce LBW (this is already commonly the standard of care and given to the control group in most studies) [47].

Use of MMS supplementation in pregnancy modestly increased birthweight in China (42 g compared to folate and 18 g compared to iron-folate) but did not have iron's impact in reducing mortality [48]. In West Java, is supplement resulted in a non-significant 40 g increase birthweight compared to iron-folate supplementation [49]; as well as increases of 52 g in Burkina Faso [50]; 70 g in Pakistan [51]; and 67 g in Niger [52]. In Vietnam, one district (A) received iron-folate, a second (B) received MMS and a third (C) received MMS and gender training. Birthweights were 105 g higher in C and 166 g higher in B, with A having about twice the rate of LBW. At age 2 years, children in B were about 2 cm taller and those in C were 1 cm taller than those in A [53].

A meta-analysis of 12 MMS trials found that the pooled estimate of increased birthweight was 24 g compared to supplementation iron-folate alone. There was about a 10% reduction in LBW, presumably due to an equal reduction in small for gestational age births. However, there was an equally large increase in gestational age births that were excessively large [54].

It is possible that the levels of nutrients used in the MMS were too low. One study in Guinea Bissau used a supplement with 15 nutrients at either one or two RDAs [55]. Among women for whom birth weights were available (who had had fewer births and more education), one RDA, resulted in a 53 g increase in birth weight and two RDAs, a 95 g increase (the latter was somewhat lower when potential confounders were adjusted for). There was no impact on the proportion born with LBWs or on mortality.

A few such trials have also taken place in industrialized countries. A recent trial of women who commonly had micronutrient deficiencies in East London, UK, though rather seriously flawed (about half the women did not complete the trial), suggested that MMS might reduce the incidence of small for gestational age deliveries [56]. A French study (1/3 loss to follow up) among apparently healthy mothers, found that MMS (which did not include iron but added Mg and Ca) increased birthweights from 3,049 to 3,300 g and resulted in a decrease in low birthweights (< 2,700 g) [57]. Maternal vitamin C levels seemed particularly important for birth weight along with zinc for birth length. In the USA, one prospective study in a low-income city for over a decade (which measured adherence to the prenatal vitamins prescribed to all participants) found substantially lower rates of preterm delivery in women who used the supplements (which contained 1 mg of folate, 25 mg zinc, 65 mg iron and 200 mg of calcium) [58]. However, there was no difference in the proportion that was small for gestational age.

Height growth

Shrimpton [59] argues that even modest reductions in LBW would substantially reduce stunting by two years of age. In one study in Vietnam, height at two years was one cm higher and rates of stunting were 8 percentage points lower (from a baseline of 29%) in two districts that received MMS compared to one that did not [53]. In France, maternal zinc supplementation alone was associated with birth length [57]. However, these studies appear to be exceptions. There was no effect of MMS on birth length in any of the 12 studies included in a meta-analysis and there was no overall impact when the data were combined [54]. Nor was such an impact seen in an MMS trial in Mexico, though in a per protocol analysis, the investigators noted that high adherence appeared more likely to lead to impact [60].

Young child morbidity

Maternal supplementation with folic acid with or without iron and zinc reduced the risk of kidney dysfunction and, to a lesser extent, metabolic syndrome among children at 6-8 y of age, however, MMS did not [61].

Neonatal mortality

In Lombok Indonesia, a large trial found that MMS through pregnancy and until 90 days after delivery reduced early infant mortality by 18% compared to iron-folate [62], with an impact of 38% among women who were anemic at baseline. LBW was decreased by 14% and 33% respectively. In a small trial of Indian women who were both undernourished (BMI < 18.5) and anemic (Hb 7-9 mg/dl), a supplement with 29 nutrients given through pregnancy resulted in substantial decreases in LBW and early neonatal morbidity [63].

In Burkina Faso [50], perinatal death was higher in the group receiving the MMS (OR: 1.78; 95% CI: 0.95, 3.32; P < 0.07), particularly among primiperas (OR: 3.44; 95% CI: 1.1, 10.7). Similarly, in Pakistan [51], MMS increased the neonatal mortality rate from 23.5 to 43.2 per thousand live births, though this was not statistically significant. A meta-analysis found no impact of MMS on any type of mortality [64].

Intellectual and motor function in young children

In Bangladesh, adding multiple micronutrients to food supplements for pregnant women led to better cognitive function in children at two years of age [65], although it failed to increase infant micronutrient levels, except for vitamin B₁₂ [66]. In China, MMS increased raw scores in mental development at one year but not earlier, but it did not impact psychomotor development [67]. A study in Nepal found no such impact however [43].

Experience with actual programs aimed at improving women's vitamin and mineral status

Reviewing all the research done so far, the overall impact of MMS would appear to be quite variable, often unimpressive and sometimes apparently negative. Impacts on fetal growth and on young child growth and development appear to be of small to moderate effect sizes. However, it is unclear whether there is an overall positive or negative impact on early infant mortality rates. In addition, recent data suggest MMS may be associated with an increased risk of dysfunctional labor [68].

Some authors do feel that this accumulated evidence is enough to call on WHO to recommend that pregnant women routinely be given MMS [69,70]. Presumably, this is because MMS is so much simpler to implement than alternative interventions. However, others need to be studied even though they are complex, if only because they are likely to be less risky [71]. The period should come after the reference citation. An example of an effective alternative is conditional cash transfer programs; one in Mexico increased birthweights by 127 g [72].

We do not know whether successful food-based interventions will result in similar impacts on birth weight. While it is clear that all needed micronutrients can be obtained in diversified but relatively common diets [73], food-based programs often show improved micronutrient status without concomitant impacts on maternal and child health [74]. Diet-based approaches are complex; no particular food or nutrient manufacturer benefits from them; thus there are actually very few that have been undertaken. Bryce et al. [35] found that none of the largest 20 countries, in which a total 80% of global stunting takes place, have national food supplementation programs for women, though sub-national programs were found in 13 of them.

For addressing infant stunting, further attention should focus on exclusive breastfeeding. It is no doubt difficult to measure, since feeding patterns vary over time and most studies only measure current practices using a 24 hour recall [75], and exclusive breastfeeding with a duration of longer than several weeks is often rare, requiring large sample sizes. One study did examine the link and found an OR of nearly 4 for both stunting as well as wasting associated with exclusive breastfeeding for a duration of less than six months [76]. Even though one trial failed to find an impact [77], given how small the impact of MMS appears to be on early stunting, trials that examine the efficacy of efforts to increase exclusive breastfeeding in reducing infant stunting deserve more attention.

The only widely implemented vitamin or mineral program for women at national level is iron-folate supplementation during pregnancy. When maternal anemia during pregnancy is successfully corrected, it results in an average 20% decline in maternal mortality [78] and improves women's cognitive functioning [79] as well as their capacity to care for their children [80-82].

In countries where anemia levels are higher than 40% during pregnancy, it is recommended that these tablets be offered to all pregnant women [83]. In others, it is often provided only to those with anemia (cut-off points for this vary from serum hemoglobin (Hb) concentrations of 7 mg/dl to 9 mg/dl), on the assumption that much, if not most, of this is linked to iron deficiency. Iron-folate supplements are effective in clinical trials in improving status of these two nutrients during the supplementation periods (usually about 6 months, sometimes 9). A few Latin American and Asian countries have had reasonable success at implementing such programs [84]. Among others, experience in Thailand and Nicaragua suggests that iron-folate supplements can reduce maternal anemia by one-third over a ten-year period [85]. However poor access (great distance to a health facility; outages at health facilities; ineligibility of the health workers who meet the women to access the tablets and thus provide them) and to a somewhat less, but still important extent, poor adherence (side effects, rumors of side effects, and unfounded fears) have plagued these programs for decades and no clear solutions have been found, especially in the poorest countries where needs are greatest [86]. Side effects increase and adherence declines as dosage increases [87].

Methods for improving iron-folate programs exist, usually linked to community-based approaches [88,89], but do increase the cost of what is otherwise an extremely low-cost intervention. But providing iron tablets once per week to adolescents, reducing anemia from 73% to 25% in four years, cost only US $0.36/beneficiary/year [90]. The semi-annual counseling and deworming it included may be the reason it was more successful than previous attempts to reach adolescents with weekly iron supplements [91,92].

The use of bovine lactoferrin instead of ferrous sulfate also appears to greatly reduce the potential for side effects [93], as does the provision of riboflavin and retinol together with ferrous sulfate [94]. Even simply providing lower doses may be useful [95].

Conclusion

Why have so few other maternal nutrition programs emerged? One reason may be that the focus has been on mortality, and only iron deficiency anemia has a substantive impact. Micronutrient supplementation and adolescent and pre-pregnancy nutrition are not included in planning and budgeting for the reduction of maternal mortality [96]. In fact, there is very little normative guidance that provides prioritized advice to policy makers on what to do to improve maternal nutrition. Major attention has focused on child rather than maternal nutrition, perhaps in part due to UNICEF advocacy [59]. Nevertheless, Shrimpton believes that in many countries, the potential for scaling up community-based approaches that will benefit women's nutrition now exists [59].

References

1. Dewey KG, Huffman SL. Maternal, infant, and young child nutrition: combining efforts to maximize impacts on child growth and micronutrient status. Food Nutr Bull. 2009. 30:S187–S189.

2. Shrimpton R, Victora CG, de Onis M, Lima RC, Blossner M, Clugston G. Worldwide timing of growth faltering: implications for nutritional interventions. Pediatrics. 2001. 107:E75.

3. Greiner T. A New Theory: Breastmilk Displacement May be the Major Cause of Nutritional Stunting. UN Standing Committee on Nutrition News. 2004. 28:63–64.

4. Greiner T. The Breastfeeding Mother's Nutrition. Breastfeeding Today. 2010. 1:10–13.

5. Underwood BA, Deckelbaum RJ, Akabas SR. Women and Micronutrients: Addressing the Gap Throughout the Life Cycle. Am J Clin Nutr. 2005. 81:1187S.

6. Zehner ER. Integrating maternal, infant, and young child nutrition: Report on the Ten Year Strategy Infant and Young Child Nutrition (IYCN) Working Group October 2008 Workshop. Food Nutr Bull. 2009. 30:S190–S196.

7. Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Premenstrual Syndrome Study Group. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol. 1998. 179:444–452.

8. Bendich A. Micronutrient's in womens health and immune function. Nutrition. 2001. 17:858–867.

9. Hofmeyr GJ, Lawrie T, Atallah A, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010. 4:CD001059.

10. Earl S, Cole ZA, Holroyd C, Cooper C, Harvey NC. Session 2: Other diseases: Dietary management of osteoporosis throughout the life course. Proc Nutr Soc. 2010. 69:25–33.

11. Nieves JW. Osteoporosis: the role of micronutrients. Am J Clin Nutr. 2005. 81:1232S–1239S.

12. Pynaert I, De Bacquer D, Matthys C, Delanghe J, Temmerman M, De Backer G, De Henauw S. Determinants of ferritin and soluble transferrin receptors as iron status parameters in young adult women. Public Health Nutr. 2009. 12:1775–1782.

13. Fraser IS. Non-contraceptive health benefits of intrauterine hormonal systems. Contraception. 2010. 82:396–403.

14. Greiner T. Are lactating women a risk group for iron deficiency anemia? Paper presented at: the First National Workshop on the Control of Nutritional Anaemia in Tanzania. 1992. Dar es Salaam.

15. Kavle JA, Stoltzfus RJ, Witter F, Tielsch JM, Khalfan SS, Caulfield LE. Association between anaemia during pregnancy and blood loss at and after delivery among women with vaginal births in Pemba Island, Zanzibar, Tanzania. J Health Popul Nutr. 2008. 26:232–240.

16. Khambalia AZ, O'Connor DL, Macarthur C, Dupuis A, Zlotkin SH. Periconceptional iron supplementation does not reduce anemia or improve iron status among pregnant women in rural Bangladesh. Am J Clin Nutr. 2009. 90:1295–1302.

17. Allen LH, Peerson JM. Maternal Micronutrient Supplementation Study Group. Impact of multiple micronutrient versus iron-folic acid supplements on maternal anemia and micronutrient status in pregnancy. Food Nutr Bull. 2009. 30:S527–S532.

18. Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr. 2005. 81:1218S–1222S.

19. Latham M. The great vitamin A fiasco. [Commentary]. World Nutrition. 2010. 1:12–44.

20. Greiner T. The case for universal supplementation is not well made. [Short communication]. World Nutrition. 2010. 1:275–282.

21. Oliveira-Menegozzo JM, Bergamaschi DP, Middleton P, East CE. Vitamin A supplementation for postpartum women. Cochrane Database Syst Rev. 2010. 6:CD005944.

22. West KP Jr, Katz J, Khatry SK, LeClerq SC, Pradhan EK, Shrestha SR, Connor PB, Dali SM, Christian P, Pokhrel RP, Sommer A. The NNIPS-2 Study Group. Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. BMJ. 1999. 318:570–575.

23. Christian P, West KP, Labrique A. Effects of maternal vitamin A or beta-carotene supplementation on maternal and infant mortality in rural Bangladesh: the JiVitA-1 trial. 2007. In : Micronutrient Forum; Istanbul; Turkey.

24. Kirkwood BR, Hurt L, Amenga-Etego S, Tawiah C, Zandoh C, Danso S, Hurt C, Edmond K, Hill Z, Ten Asbroek G, Fenty J, Owusu-Agyei S, Campbell O, Arthur P. ObaapaVitA Trial Team. Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial. Lancet. 2010. 375:1640–1649.

25. Kirkwood B. ObaapaViTa Trial Team. Effect of vitamin A supplementation on maternal survival [Letter to the editor: Reply]. Lancet. 2010. 376:874.

26. London RS, Murphy L, Kitlowski KE, Reynolds MA. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. J Reprod Med. 1987. 32:400–404.

27. DiGirolamo AM, Ramirez-Zea M. Role of zinc in maternal and child mental health. Am J Clin Nutr. 2009. 89:940S–945S.

28. Sanghvi T, Van Ameringen M, Baker J, Fiedler J. Vitamin and mineral deficiencies technical situation analysis: a report for the Ten Year Strategy for the Reduction of Vitamin and Mineral Deficiencies, Summary. Food Nutr Bull. 2007. 28:S160–S164.

29. Busby A, Abramsky L, Dolk H, Armstrong B, Addor MC, Anneren G, Armstrong N, Baguette A, Barisic I, Berghold A, Bianca S, Braz P, Calzolari E, Christiansen M, Cocchi G, Daltveit AK, De Walle H, Edwards G, Gatt M, Gener B, Gillerot Y, Gjergja R, Goujard J, Haeusler M, Latos-Bielenska A, McDonnell R, Neville A, Olars B, Portillo I, Ritvanen A, Robert-Gnansia E, Rösch C, Scarano G, Steinbicker V. Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol. 2005. 20:393–402.

30. Beinner MA, Soares ADN, Barros ALA, Monteiro MAM. Sensory evaluation of rice fortified with iron. Ciencia E Tecnologia De Alimentos. 2010. 30:516–519.

31. Thompson MD, Cole DE, Ray JG. Vitamin B-12 and neural tube defects: the Canadian experience. Am J Clin Nutr. 2009. 89:697S–701S.

32. Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ, Bhat DS, Naik SS, Coyaji KJ, Joglekar CV, Joshi N, Lubree HG, Deshpande VU, Rege SS, Fall CH. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia. 2008. 51:29–38.

33. Wieringa FT, Dijkhuizen MA, Muhilal , Van der Meer JW. Maternal micronutrient supplementation with zinc and β-carotene affects morbidity and immune function of infants during the first 6 months of life. Eur J Clin Nutr. 2010. 64:1072–1079.

34. Iannotti LL, Zavaleta N, León Z, Huasquiche C, Shankar AH, Caulfield LE. Maternal zinc supplementation reduces diarrheal morbidity in peruvian infants. J Pediatr. 2010. 156:960–964.

35. Bryce J, Coitinho D, Darnton-Hill I, Pelletier D, Pinstrup-Andersen P. Maternal and Child Undernutrition Study Group. Maternal and child undernutrition: effective action at national level. Lancet. 2008. 371:510–526.

36. de Onis M, Villar J, Gülmezoglu M. Nutritional interventions to prevent intrauterine growth retardation: evidence from randomized controlled trials. Eur J Clin Nutr. 1998. 52:S83–S93.

37. Merialdi M, Carroli G, Villar J, Abalos E, Gülmezoglu AM, Kulier R, de Onis M. Nutritional interventions during pregnancy for the prevention or treatment of impaired fetal growth: an overview of randomized controlled trials. J Nutr. 2003. 133:1626S–1631S.

38. Mason JB, Deitchler M, Gilman A, Gillenwater K, Shuaib M, Hotchkiss D, Mason K, Mock N, Sethuraman K. Iodine fortification is related to increased weight-for-age and birthweight in children in Asia. Food Nutr Bull. 2002. 23:292–308.

39. Cogswell ME, Parvanta I, Ickes L, Yip R, Brittenham GM. Iron supplementation during pregnancy, anemia, and birth weight: a randomized controlled trial. Am J Clin Nutr. 2003. 78:773–781.

40. Semba RD, de Pee S, Hess SY, Sun K, Sari M, Bloem MW. Child malnutrition and mortality among families not utilizing adequately iodized salt in Indonesia. Am J Clin Nutr. 2008. 87:438–444.

41. Saaka M, Oosthuizen J, Beatty S. Effect of prenatal zinc supplementation on birthweight. J Health Popul Nutr. 2009. 27:619–631.

42. Goldenberg RL, Tamura T, Neggers Y, Copper RL, Johnston KE, DuBard MB, Hauth JC. The effect of zinc supplementation on pregnancy outcome. JAMA. 1995. 274:463–468.

43. Christian P, Murray-Kolb LE, Khatry SK, Katz J, Schaefer BA, Cole PM, Leclerq SC, Tielsch JM. Prenatal micronutrient supplementation and intellectual and motor function in early school-aged children in Nepal. JAMA. 2010. 304:2716–2723.

44. Katz J, Khatry SK, Leclerq SC, Mullany LC, Yanik EL, Stoltzfus RJ, Siegel EH, Tielsch JM. Daily supplementation with iron plus folic acid, zinc, and their combination is not associated with younger age at first walking unassisted in malnourished preschool children from a deficient population in rural Nepal. J Nutr. 2010. 140:1317–1321.

45. Caulfield LE, Putnick DL, Zavaleta N, Lazarte F, Albornoz C, Chen P, Dipietro JA, Bornstein MH. Maternal gestational zinc supplementation does not influence multiple aspects of child development at 54 mo of age in Peru. Am J Clin Nutr. 2010. 92:130–136.

46. Ekström EC, Hyder SM, Chowdhury AM, Chowdhury SA, Lönnerdal B, Habicht JP, Persson LA. Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh: disentangling the issues. Am J Clin Nutr. 2002. 76:1392–1400.

47. Haider BA, Bhutta ZA. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev. 2006. 18:CD004905.

48. Zeng L, Dibley MJ, Cheng Y, Dang S, Chang S, Kong L, Yan H. Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial. BMJ. 2008. 337:a2001.

49. Sunawang , Utomo B, Hidayat A, Kusharisupeni , Subarkah . Preventing low birthweight through maternal multiple micronutrient supplementation: a cluster-randomized, controlled trial in Indramayu, West Java. Food Nutr Bull. 2009. 30:S488–S495.

50. Roberfroid D, Huybregts L, Lanou H, Henry MC, Meda N, Menten J, Kolsteren P. MISAME Study Group. Effects of maternal multiple micronutrient supplementation on fetal growth: a double-blind randomized controlled trial in rural Burkina Faso. Am J Clin Nutr. 2008. 88:1330–1340.

51. Bhutta ZA, Rizvi A, Raza F, Hotwani S, Zaidi S, Moazzam Hossain S, Soofi S, Bhutta S. A comparative evaluation of multiple micronutrient and iron-folic acid supplementation during pregnancy in Pakistan: impact on pregnancy outcomes. Food Nutr Bull. 2009. 30:S496–S505.

52. Zagré NM, Desplats G, Adou P, Mamadoultaibou A, Aguayo VM. Prenatal multiple micronutrient supplementation has greater impact on birthweight than supplementation with iron and folic acid: a cluster-randomized, double-blind, controlled programmatic study in rural Niger. Food Nutr Bull. 2007. 28:317–327.

53. Huy ND, Le Hop T, Shrimpton R, Hoa CV. An effectiveness trial of multiple micronutrient supplementation during pregnancy in Vietnam: impact on birthweight and on stunting in children at around 2 years of age. Food Nutr Bull. 2009. 30:S506–S516.

54. Fall CH, Fisher DJ, Osmond C, Margetts BM. Maternal Micronutrient Supplementation Study Group. T Multiple micronutrient supplementation during pregnancy in low-income countries: a meta-analysis of effects on birth size and length of gestation. Food Nutr Bull. 2009. 30:S533–S546.

55. Kaestel P, Michaelsen KF, Aaby P, Friis H. Effects of prenatal multimicronutrient supplements on birth weight and perinatal mortality: a randomised, controlled trial in Guinea-Bissau. Eur J Clin Nutr. 2005. 59:1081–1089.

56. Brough L, Rees GA, Crawford MA, Morton RH, Dorman EK. Effect of multiple-micronutrient supplementation on maternal nutrient status, infant birth weight and gestational age at birth in a low-income, multi-ethnic population. Br J Nutr. 2010. 104:437–445.

57. Hininger I, Favier M, Arnaud J, Faure H, Thoulon JM, Hariveau E, Favier A, Roussel AM. Effects of a combined micronutrient supplementation on maternal biological status and newborn anthropometrics measurements: a randomized double-blind, placebo-controlled trial in apparently healthy pregnant women. Eur J Clin Nutr. 2004. 58:52–59.

58. Scholl TO, Hediger ML, Bendich A, Schall JI, Smith WK, Krueger PM. Use of multivitamin/mineral prenatal supplements: influence on the outcome of pregnancy. Am J Epidemiol. 1997. 146:134–141.

59. Shrimpton R. UNSCN. Maternal nutrition and the intergenerational cycle of growth failure. Progress in Nutrition, 6th Report on the World Nutrition Situation. 2010. Geneva: United Nations System Standing Committee on Nutrition.

60. Ramakrishnan U, Neufeld LM, Flores R, Rivera J, Martorell R. Multiple micronutrient supplementation during early childhood increases child size at 2 y of age only among high compliers. Am J Clin Nutr. 2009. 89:1125–1131.

61. Stewart CP, Christian P, Schulze KJ, Leclerq SC, West KP Jr, Khatry SK. Antenatal micronutrient supplementation reduces metabolic syndrome in 6- to 8-year-old children in rural Nepal. J Nutr. 2009. 139:1575–1581.

62. Shankar AH, Jahari AB, Sebayang SK, Aditiawarman , Apriatni M, Harefa B, Muadz H, Soesbandoro SD, Tjiong R, Fachry A, Shankar AV, Atmarita , Prihatini S, Sofia G. Supplementation with Multiple Micronutrients Intervention Trial (SUMMIT) Study Group. Effect of maternal multiple micronutrient supplementation on fetal loss and infant death in Indonesia: a double-blind cluster-randomised trial. Lancet. 2008. 371:215–227.

63. Gupta P, Ray M, Dua T, Radhakrishnan G, Kumar R, Sachdev HP. Multimicronutrient supplementation for undernourished pregnant women and the birth size of their offspring: a double-blind, randomized, placebo-controlled trial. Arch Pediatr Adolesc Med. 2007. 161:58–64.

64. Ronsmans C, Fisher DJ, Osmond C, Margetts BM, Fall CH. Maternal Micronutrient Supplementation Study Group. Multiple micronutrient supplementation during pregnancy in low-income countries: a meta-analysis of effects on stillbirths and on early and late neonatal mortality. Food Nutr Bull. 2009. 30:S547–S555.

65. Tofail F, Persson LA, El Arifeen S, Hamadani JD, Mehrin F, Ridout D, Ekström EC, Huda SN, Grantham-McGregor SM. Effects of prenatal food and micronutrient supplementation on infant development: a randomized trial from the Maternal and Infant Nutrition Interventions, Matlab (MINIMat) study. Am J Clin Nutr. 2008. 87:704–711.

66. Eneroth H, El Arifeen S, Persson LA, Lönnerdal B, Hossain MB, Stephensen CB, Ekström EC. Maternal multiple micronutrient supplementation has limited impact on micronutrient status of Bangladeshi infants compared with standard iron and folic acid supplementation. J Nutr. 2010. 140:618–624.

67. Li Q, Yan H, Zeng L, Cheng Y, Liang W, Dang S, Wang Q, Tsuji I. Effects of maternal multimicronutrient supplementation on the mental development of infants in rural western China: follow-up evaluation of a double-blind, randomized, controlled trial. Pediatrics. 2009. 123:E685–E692.

68. Christian P, Khatry SK, LeClerq SC, Dali SM. Effects of prenatal micronutrient supplementation on complications of labor and delivery and puerperal morbidity in rural Nepal. Int J Gynaecol Obstet. 2009. 106:3–7.

69. Dalmiya N, Darnton-Hill I, Schultink W, Shrimpton R. Multiple micronutrient supplementation during pregnancy: a decade of collaboration in action. Food Nutr Bull. 2009. 30:S477–S479.

70. Shrimpton R, Huffman SL, Zehner ER, Darnton-Hill I, Dalmiya N. Multiple micronutrient supplementation during pregnancy in developing-country settings: policy and program implications of the results of a meta-analysis. Food Nutr Bull. 2009. 30:S556–S573.

71. McLaren DS. Multiple Micronutrients and "Hidden Hunger". Sight and Live Magazine. 2008. 9. Basel, Switzerland: Sight and Life, DSM;6–12.

72. Barber SL, Gertler PJ. The impact of Mexico's conditional cash transfer programme, Oportunidades, on birthweight. Trop Med Int Health. 2008. 13:1405–1414.

73. Uauy-Dagach R, Hertrampf E. Bowman B, Russell R, editors. Food-based dietary recommendations: possibilities and limitations. Present Knowledge in Nutrition. 2001. 9:8th ed. Washington DC: ILSI Press;636–649.

74. Olney DK, Talukder A, Iannotti LL, Ruel MT, Quinn V. Assessing impact and impact pathways of a homestead food production program on household and child nutrition in Cambodia. Food Nutr Bull. 2009. 30:355–369.

75. Aarts C, Kylberg E, Hörnell A, Hofvander Y, Gebre-Medhin M, Greiner T. How exclusive is exclusive breastfeeding? A comparison of data since birth with current status data. Int J Epidemiol. 2000. 29:1041–1046.

76. Hien NN, Kam S. Nutritional status and the characteristics related to malnutrition in children under five years of age in Nghean, Vietnam. J Prev Med Public Health. 2008. 41:232–240.

77. Bhandari N, Bahl R, Mazumdar S, Martines J, Black RE, Bhan MK. Infant Feeding Study Group. Effect of community-based promotion of exclusive breastfeeding on diarrhoeal illness and growth: a cluster randomised controlled trial. Lancet. 2003. 361:1418–1423.

78. Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, Haider BA, Kirkwood B, Morris SS, Sachdev HP, Shekar M. Maternal and Child Undernutrition Study Group. What works? Interventions for maternal and child undernutrition and survival. Lancet. 2008. 371:417–440.

79. Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L, Irlam J, Isaacs W, Sive A, Tomlinson M. Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr. 2005. 135:267–272.

80. Perez EM, Hendricks MK, Beard JL, Murray-Kolb LE, Berg A, Tomlinson M, Irlam J, Isaacs W, Njengele T, Sive A, Vernon-Feagans L. Mother-infant interactions and infant development are altered by maternal iron deficiency anemia. J Nutr. 2005. 135:850–855.

81. Frith AL, Naved RT, Ekström EC, Rasmussen KM, Frongillo EA. Micronutrient supplementation affects maternal-infant feeding interactions and maternal distress in Bangladesh. Am J Clin Nutr. 2009. 90:141–148.

82. Murray-Kolb LE, Beard JL. Iron deficiency and child and maternal health. Am J Clin Nutr. 2009. 89:946S–950S.

83. WHO/UNICEF. Focusing on anemia: towards an integrated approach for effective anemia control. 2004. Geneva: World Health Organization.

84. Palmer AP, Stewart CP. Micronutrients, Health and Development: Evidence-Based Programs. Sight and Live Magazine. 2009. Basel, Switzerland: Sight and Live, DSM;25–33.

85. Sanghvi TG, Harvey PW, Wainwright E. Maternal iron-folic acid supplementation programs: evidence of impact and implementation. Food Nutr Bull. 2010. 31:S100–S107.

86. Gillespie S, Kevany J, Mason J. Controlling Iron Deficiency. 1991. Geneva: ACC/SCN.

87. Souza AI, Batista Filho M, Bresani CC, Ferreira LO, Figueiroa JN. Adherence and side effects of three ferrous sulfate treatment regimens on anemic pregnant women in clinical trials. Cad Saude Publica. 2009. 25:1225–1233.

88. Shankar AV, Asrilla Z, Kadha JK, Sebayang S, Apriatni M, Sulastri A, Sunarsih E, Shankar AH. SUMMIT Study Group. Programmatic effects of a large-scale multiple-micronutrient supplementation trial in Indonesia: using community facilitators as intermediaries for behavior change. Food Nutr Bull. 2009. 30:S207–S214.

89. Ndiaye M, Siekmans K, Haddad S, Receveur O. Impact of a positive deviance approach to improve the effectiveness of an iron-supplementation program to control nutritional anemia among rural Senegalese pregnant women. Food Nutr Bull. 2009. 30:128–136.

90. Vir SC, Singh N, Nigam AK, Jain R. Weekly iron and folic acid supplementation with counseling reduces anemia in adolescent girls: a large-scale effectiveness study in Uttar Pradesh, India. Food Nutr Bull. 2008. 29:186–194.

91. Soekarjo DD, Pee Sd S, Kusin JA, Schreurs WH, Schultink W, Muhilal , Bloem MW. Effectiveness of weekly vitamin A (10,000 IU) and iron (60 mg) supplementation for adolescent boys and girls through schools in rural and urban East Java, Indonesia. Eur J Clin Nutr. 2004. 58:927–937.

92. Ahmed F, Khan MR, Akhtaruzzaman M, Karim R, Marks GC, Banu CP, Nahar B, Williams G. Efficacy of twice-weekly multiple micronutrient supplementation for improving the hemoglobin and micronutrient status of anemic adolescent schoolgirls in Bangladesh. Am J Clin Nutr. 2005. 82:829–835.

93. Paesano R, Berlutti F, Pietropaoli M, Pantanella F, Pacifici E, Goolsbee W, Valenti P. Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women. Biometals. 2010. 23:411–417.

94. Ma AG, Schouten EG, Zhang FZ, Kok FJ, Yang F, Jiang DC, Sun YY, Han XX. Retinol and riboflavin supplementation decreases the prevalence of anemia in Chinese pregnant women taking iron and folic Acid supplements. J Nutr. 2008. 138:1946–1950.

95. Gill SK, Nguyen P, Koren G. Adherence and tolerability of iron-containing prenatal multivitamins in pregnant women with pre-existing gastrointestinal conditions. J Obstet Gynaecol. 2009. 29:594–598.

96. Darmstadt GL, Walker N, Lawn JE, Bhutta ZA, Haws RA, Cousens S. Saving newborn lives in Asia and Africa: cost and impact of phased scale-up of interventions within the continuum of care. Health Policy Plan. 2008. 23:101–117.

TOOLS

Similar articles